Gwen is a Career Development Fellow at the Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance.
The HPRU is a partnership between Imperial College London, Public Health England, Cambridge University Veterinary School, the Wellcome Trust Sanger Institute and Imperial College Health Partners North West London Academic Health Science Network. The Unit was funded, along with 12 others in priority areas from immunisation to radiation hazards, to bring Universities to work in partnership with Public Health England to support excellent health protection research relevant to the needs of Public Health England.
Prior to this, Gwen worked as a Research Fellow at the London School of Hygiene and Tropical Medicine as part of the TB Modelling Group. Her work there investigated the impact of existing and potential interventions to control TB disease at the population level. She also worked on projects exploring the impact of antibiotic resistance on the fitness of Mycobacterium tuberculosis. Gwen has a PhD from UCL investigating the spread of antibiotic resistance within the hospital associated pathogen methicillin resistant Staphylococcus aureus.
et al., 2018, Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling study, Bmc Medicine, Vol:16, ISSN:1741-7015
et al., 2018, Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals, Bmc Medicine, Vol:16, ISSN:1741-7015
et al., 2017, Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden, Clinical Infectious Diseases, Vol:66, ISSN:1058-4838, Pages:612-616
et al., 2017, Using data from macaques to predict gamma interferon responses after mycobacterium bovis BCG vaccination in humans: a proof-of-concept study of immunostimulation/immunodynamic modeling methods, Clinical and Vaccine Immunology, Vol:24, ISSN:1556-679X
et al., 2016, Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines, Human Vaccines and Immunotherapeutics, Vol:12, ISSN:2164-5515, Pages:2813-2832